PMID- 24236988 OWN - NLM STAT- MEDLINE DCOM- 20141105 LR - 20240520 IS - 1476-5381 (Electronic) IS - 0007-1188 (Print) IS - 0007-1188 (Linking) VI - 171 IP - 6 DP - 2014 Mar TI - Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats. PG - 1435-47 LID - 10.1111/bph.12519 [doi] AB - BACKGROUND AND PURPOSE: Many young people consume ecstasy as a recreational drug and often in combination with cannabis. In this study, we aimed to mimic human consumption patterns and investigated, in male and female animals, the long-term effects of Delta(9) -tetrahydrocannabinol (THC) and 3,4-methylenedioxymethamphetamine (MDMA) on diverse neuroinflammation and neurotoxic markers. EXPERIMENTAL APPROACH: Male and female Wistar rats were chronically treated with increasing doses of THC and/or MDMA during adolescence. The effects of THC and/or MDMA on glial reactivity and on serotoninergic and cannabinoid systems were assessed by immunohistochemistry in the hippocampus and parietal cortex. KEY RESULTS: THC increased the area staining for glial fibrilar acidic protein in both sexes. In males, both drugs, either separately or in combination, increased the proportion of reactive microglia cells [ionized calcium binding adaptor molecule 1 (Iba-1)]. In contrast, in females, each drug, administered alone, decreased of this proportion, whereas the combination of both drugs resulted in a 'normalization' to control values. In males, MDMA reduced the number of SERT positive fibres, THC induced the opposite effect and the group receiving both drugs did not significantly differ from the controls. In females, MDMA reduced the number of SERT positive fibres and the combination of both drugs counteracted this effect. THC also reduced immunostaining for CB1 receptors in females and this effect was aggravated by the combination with MDMA. CONCLUSIONS AND IMPLICATIONS: Adolescent exposure of rats to THC and/or MDMA induced long-term, sex-dependent neurochemical and glial alterations, and revealed interactions between the two drugs. LINKED ARTICLES: This article is part of a themed section on Cannabinoids 2013. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue-6. CI - (c) 2013 The British Pharmacological Society. FAU - Lopez-Rodriguez, Ana Belen AU - Lopez-Rodriguez AB AD - Department of Animal Physiology (Animal Physiology II), Faculty of Biology, Complutense University of Madrid - Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (IdISSC), Madrid, Spain; Instituto Cajal, Consejo Superior de Investigaciones Cientificas (CSIC), Madrid, Spain. FAU - Llorente-Berzal, Alvaro AU - Llorente-Berzal A FAU - Garcia-Segura, Luis M AU - Garcia-Segura LM FAU - Viveros, Maria-Paz AU - Viveros MP LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Br J Pharmacol JT - British journal of pharmacology JID - 7502536 RN - 0 (Aif1 protein, rat) RN - 0 (Calcium-Binding Proteins) RN - 0 (Cannabinoids) RN - 0 (Glial Fibrillary Acidic Protein) RN - 0 (Microfilament Proteins) RN - 0 (Receptor, Cannabinoid, CB1) RN - 333DO1RDJY (Serotonin) RN - 7J8897W37S (Dronabinol) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Adolescent MH - Animals MH - Calcium-Binding Proteins/metabolism MH - Cannabinoids/*metabolism MH - Dronabinol/*pharmacology MH - Encephalitis/metabolism/*physiopathology MH - Female MH - Glial Fibrillary Acidic Protein/metabolism MH - Humans MH - Male MH - Microfilament Proteins/metabolism MH - N-Methyl-3,4-methylenedioxyamphetamine/*pharmacology MH - Rats MH - Rats, Wistar MH - Receptor, Cannabinoid, CB1/metabolism MH - Serotonin/*metabolism MH - *Sex Factors PMC - PMC3954483 OTO - NOTNLM OT - CB1 receptor OT - MDMA OT - THC OT - adolescence OT - astrocytes OT - reactive microglia OT - serotonin transporter OT - sex differences EDAT- 2013/11/19 06:00 MHDA- 2014/11/06 06:00 PMCR- 2015/03/01 CRDT- 2013/11/19 06:00 PHST- 2013/05/31 00:00 [received] PHST- 2013/11/07 00:00 [revised] PHST- 2013/11/13 00:00 [accepted] PHST- 2013/11/19 06:00 [entrez] PHST- 2013/11/19 06:00 [pubmed] PHST- 2014/11/06 06:00 [medline] PHST- 2015/03/01 00:00 [pmc-release] AID - 10.1111/bph.12519 [doi] PST - ppublish SO - Br J Pharmacol. 2014 Mar;171(6):1435-47. doi: 10.1111/bph.12519.